These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 36347997)

  • 1. Alpha lipoamide inhibits diabetic kidney fibrosis via improving mitochondrial function and regulating RXRα expression and activation.
    Zhang HF; Liu HM; Xiang JY; Zhou XC; Wang D; Chen RY; Tan WL; Liang LQ; Liu LL; Shi MJ; Zhang F; Xiao Y; Zhou YX; Zhang T; Tang L; Guo B; Wang YY
    Acta Pharmacol Sin; 2023 May; 44(5):1051-1065. PubMed ID: 36347997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of CDX2 in renal tubular lesions during diabetic kidney disease.
    Liu H; Yan R; Liang L; Zhang H; Xiang J; Liu L; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Zhou Y; Shi M; Wang Y; Guo B
    Aging (Albany NY); 2021 Feb; 13(5):6782-6803. PubMed ID: 33621200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
    Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
    Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.
    Kang MK; Park SH; Choi YJ; Shin D; Kang YH
    J Mol Med (Berl); 2015 Jul; 93(7):759-72. PubMed ID: 26062793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [1, 25-(OH)
    Huang C; Dong R; Li Z; Yuan J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Apr; 39(4):325-331. PubMed ID: 37087550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease.
    Hu Y; Tang W; Liu W; Hu Z; Pan C
    Drug Des Devel Ther; 2022; 16():1605-1620. PubMed ID: 35669284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATF5 regulates tubulointerstitial injury in diabetic kidney disease via mitochondrial unfolded protein response.
    Liu Y; Zhang L; Zhang S; Liu J; Li X; Yang K; Yang D; Liu Y; Sun L; Liu F; Xiao L
    Mol Med; 2023 Apr; 29(1):57. PubMed ID: 37095454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP22 aggravated diabetic renal tubulointerstitial fibrosis progression through deubiquitinating and stabilizing Snail1.
    Zhao X; He X; Wei W; Huang K
    Eur J Pharmacol; 2023 May; 947():175671. PubMed ID: 37001578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schisandrin B Alleviates Renal Tubular Cell Epithelial-Mesenchymal Transition and Mitochondrial Dysfunction by Kielin/Chordin-like Protein Upregulation via Akt Pathway Inactivation and Adenosine 5'-Monophosphate (AMP)-Activated Protein Kinase Pathway Activation in Diabetic Kidney Disease.
    Liu W; Li F; Guo D; Du C; Zhao S; Li J; Yan Z; Hao J
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis.
    Yang T; Heng C; Zhou Y; Hu Y; Chen S; Wang H; Yang H; Jiang Z; Qian S; Wang Y; Wang J; Zhu X; Du L; Yin X; Lu Q
    Metabolism; 2020 Jul; 108():154258. PubMed ID: 32376130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ZnT8 on epithelial-to-mesenchymal transition and tubulointerstitial fibrosis in diabetic kidney disease.
    Zhang X; Guan T; Yang B; Gu HF; Chi Z
    Cell Death Dis; 2020 Jul; 11(7):544. PubMed ID: 32681069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FHL2 promotes tubular epithelial-to-mesenchymal transition through modulating β-catenin signalling.
    Cai T; Sun D; Duan Y; Qiu Y; Dai C; Yang J; He W
    J Cell Mol Med; 2018 Mar; 22(3):1684-1695. PubMed ID: 29193729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NQO1 alleviates renal fibrosis by inhibiting the TLR4/NF-κB and TGF-β/Smad signaling pathways in diabetic nephropathy.
    Qiu D; Song S; Chen N; Bian Y; Yuan C; Zhang W; Duan H; Shi Y
    Cell Signal; 2023 Aug; 108():110712. PubMed ID: 37196773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide-induced protein 2.4 ameliorates high glucose-induced epithelial-mesenchymal transition by activating adenosine monophosphate-activated protein kinase pathway in renal tubular cells.
    Li F; Guo D; Zhi S; Jia K; Wang Y; Zhang A; Pei Y; Hao J
    Int J Biochem Cell Biol; 2022 Jan; 142():106117. PubMed ID: 34801707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMP-7/Smads-induced inhibitor of differentiation 2 (Id2) upregulation and Id2/Twist interaction was involved in attenuating diabetic renal tubulointerstitial fibrosis.
    Xiao Y; Jiang X; Peng C; Zhang Y; Xiao Y; Liang D; Shi M; Wang Y; Zhang F; Guo B
    Int J Biochem Cell Biol; 2019 Nov; 116():105613. PubMed ID: 31539631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glis2 inhibits the epithelial-mesenchymal transition and apoptosis of renal tubule cells by regulating the β-catenin signalling pathway in diabetic kidney disease.
    He L; Li Q; Du C; Xue Y; Yu P
    Biochem Biophys Res Commun; 2022 Jun; 607():73-80. PubMed ID: 35367831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connexin 43 prevents the progression of diabetic renal tubulointerstitial fibrosis by regulating the SIRT1-HIF-1α signaling pathway.
    Sun X; Huang K; Haiming X; Lin Z; Yang Y; Zhang M; Liu P; Huang H
    Clin Sci (Lond); 2020 Jul; 134(13):1573-1592. PubMed ID: 32558900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Farnesoid X receptor activation protects against renal fibrosis via modulation of β-catenin signaling.
    Sun DQ; Yuan F; Fu MZ; Zhong MY; Zhang SL; Lu Y; Targher G; Byrne CD; Zheng MH; Yuan WJ
    Mol Metab; 2024 Jan; 79():101841. PubMed ID: 38036169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of andrographolide on renal tubulointersticial injury and fibrosis. Evidence of its mechanism of action.
    Liu W; Liang L; Zhang Q; Li Y; Yan S; Tang T; Ren Y; Mo J; Liu F; Chen X; Lan T
    Phytomedicine; 2021 Oct; 91():153650. PubMed ID: 34332282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supplemented Gegen Qinlian Decoction Formula attenuates podocyte mitochondrial fission and renal fibrosis in diabetic kidney disease by inhibiting TNF-α-mediated necroptosis, compared with empagliflozin.
    Wang Y; Yu L; Li Y; Cha S; Shi L; Wang J; Ge F; Huang C; Huang H; Tu Y; Wan Y; Shen S
    J Ethnopharmacol; 2024 Nov; 334():118572. PubMed ID: 39025164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.